FGEN (fibrogen.com) Bozor qiymatining balans qiymatiga nisbati

FibroGen Inc (FGEN) kompaniyasining rasmiy ramzlari

FibroGen, Inc. (FGEN) ning rivojlanishi ilmiy-tadqiqot va ishlanmalar loyihalarining muvaffaqiyatiga va kuyish darajasiga juda bog'liq bo'lib, bu aktiv qiymati -2.29 bo'lgan jadvalda aks ettirilgan. Biznes patent qonunchiligidan foydalanadi, tasdiqlangan davolash usullarini global shartnomalar orqali logistika xarajatlarini qoplamasdan kengaytiradi. Sun'iy intellekt va bioreaktor avtomatlashtirishni joriy etish anemiyaga qarshi dorilarni ishlab chiqishni tezlashtiradi, ammo yakuniy nazorat shifokorlarda qoladi.

FGEN FibroGen Corporation: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 08.01.2026 oraligʻida

FibroGen Inc (FGEN) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi FibroGen, Inc.|FGEN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati FibroGen Corp|FGEN - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati FibroGen|FGEN - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati fibrogen.com|FGEN - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati FibroGen, Inc.|FGEN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati FibroGen Corp|FGEN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar FibroGen Corp
Kompaniyaning dastlabki tahlili:FibroGen, Inc. - FGEN
FibroGen Corp original mahsuloti

Ushbu koeffitsiyent bozor qiymatini sof aktivlar bilan solishtirish orqali emitentning investitsiya ishonchliligini belgilaydi. Mazkur metrika bozor kompaniya kapitali uchun to'lashga tayyor bo'lgan premiumni o'lchaydi. FibroGen, Inc. (FGEN) uchun P/BV grafigini tahlil qilish orqali investor biznes uchun to'lovning ortiqchalik darajasini baholaydi. FibroGen, Inc. (FGEN) uchun ushbu premiumning barqarorligi anemiya bo'yicha patentlangan dori vositalariga bo'lgan uzoq muddatli talab bilan bog'liq. Ushbu kasalliklarning surunkali tabiati bashorat qilinadigan pul oqimini kafolatlaydi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com (ENTX)|MindWalk Holdings Inc. (HYFT) - Bozor kapitallashuvining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ABVC BioPharma Inc. ABVC|Bozor kapitallashuvining balans qiymatiga nisbati CPIX (Cumberland Pharma)|QNTM - Balans qiymatiga nisbatan bozor kapitallashuvi|Telomir Pharmaceuticals (TELO) - Bozor kapitallashuvining balans qiymatiga nisbati|RANI (Rani Therapeutics Holdings, Inc.) - Bozor qiymatining balans qiymatiga nisbati|SNYR - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati RLYB|Lexaria Bioscience - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Pulmatrix Corporation (PULM)|PTHL (Pheton Holdings) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|IBO: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati tnfpharma.com|Kapitallashuvning balans qiymatiga nisbati cbdMD|PRFX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|LIPO (Lipella Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OPTN (OptiNose Inc)|PIRS - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Procaps Group Corp PROC|PTPI: Bozor kapitallashuvining balans qiymatiga nisbati|qlsyy.net (QLI) - Kapitallashuvning sof aktivlarga nisbati|ACELYRIN - Kapitallashuvning sof aktivlarga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor kapitallashuvi